AI Enhances Cancer Diagnosis

This is a news story, published by MSN, that relates primarily to Tsia news.

Tsia news

For more Tsia news, you can click here:

more Tsia news

News about Ai research

For more Ai research news, you can click here:

more Ai research news

MSN news

For more news from MSN, you can click here:

more news from MSN

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best tech news, business news, entertainment news, and much more. If you like this article about Ai research, you might also like this article about

CytoMAD

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cell imaging inconsistencies news, unbiased cell image analysis news, news about Ai research, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

cell imaging

Medical Xpress - medical research advances and health news

•

Technology

AI-driven tool speeds up cancer diagnosis with precise cell imaging

Summary

Nutrition label

89% Informative

CytoMAD allows fast and cost-effective "label-free" imaging of human cells to help clinicians assess a patients' tumor at the precision of individual cells, and also determine whether patients have the risk of metastasis.

The new tool uses AI to automatically correct cell imaging inconsistencies, enhance cell images, and extract previously undetectable information from cell images.

CytoMAD could reduce the often-lengthy process of drug screening, through the adoption of the time-saving "label free method" Professor Tsia 's team has applied for research funding to conduct clinical trials among lung cancer patients over a three-year period.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful